Synthesize Bio logo

Synthesize Bio

synthesize.bio

Synthesize Bio develops generative genomics models that predict how human tissues and cells respond to drugs, diseases, and experimental interventions. Its platform enables drug development teams, clinical development teams, and biopharma partners to simulate clinical trial outcomes, optimize trial design, identify biomarkers, and augment limited datasets with virtual human cohorts. The organization aims to accelerate and de-risk clinical development by providing actionable predictions and insights grounded in large-scale RNA-seq data.

Facts

HQ
Seattle, WA, US
Sectors
Biotechnology Research
Founded
2023
Type
Corporation Seattle business license
Employees
21
Registered name
Synthesize Bio Seattle business license
Stage
Seed
Founders
Robert Bradley, PhD, Jeff Leek, PhD

Is this your organization? Claim it

Recent coverage

Front-page news, podcasts and videos about Synthesize Bio

See all 19

AI House hosts Demo Day in Seattle with 25 startups pitching to investors flown in from Boston, New York, Colorado and the Bay Area

AI House hosted a demo day in Seattle where 25 early-stage startups—many outside the incubator’s portfolio—pitched to investors flown in from Boston, New York, Colorado, the Bay Area and other cities to increase outside capital for local founders. Organizers aimed to showcase diverse Seattle startups, from revenue-generating companies to ambitious technologists, and attracted both national and local venture investors.

Seattle Startup Pauling.AI Uses AI to Cut Drug Discovery from Months to Weeks, Founded by Ex-Google Exec Javier Tordable in 2024

Seattle startup Pauling.AI uses AI to automate early drug discovery steps, reducing timelines from months to weeks and aiming to greatly increase new drug approvals. Founded in 2024 by former Google technical director Javier Tordable, the company offers a 'scientist-as-a-service' platform to assist researchers with computational chemistry and drug candidate modeling.

People

  • Jeff Leek
    Jeff Leek Co-founder, Co-CEO
  • Alice M. Walsh Executive, COO

Online

Questions about Synthesize Bio

What is Synthesize Bio?

Synthesize Bio is a startup based in Seattle, WA, US that develops generative genomics models to predict how human tissues and cells respond to drugs, diseases, and experimental interventions.

What is Synthesize Bio known for?

Synthesize Bio uses large-scale RNA-seq data to help drug development teams simulate clinical trial outcomes, optimize trial design, identify biomarkers, and augment limited datasets with virtual human cohorts.

What has Synthesize Bio been in the news for?

GeekWire reported in September 2026 on an AI House Demo Day in Seattle where startups pitched to investors visiting from Boston, New York, Colorado and the Bay Area. LinkedIn also featured a September 2026 account by Taylor Soper listing founders and startups that pitched at Demo Day.

Who are the people behind Synthesize Bio?

Jeff Leek is co-founder and co-CEO of Synthesize Bio. Alice M. Walsh is an executive and COO.

Who invested in Synthesize Bio, and how much has it raised?

Members of Seattle Flow see Synthesize Bio's funding rounds, amounts and investors on its Funding tab. Joining is free.

Where is Synthesize Bio based?

Synthesize Bio is based in Seattle, WA, US.